.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Mallinckrodt
Moodys
Deloitte
Merck
QuintilesIMS
Julphar
Citi
Medtronic

Generated: December 15, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,241,649

« Back to Dashboard

Claims for Patent: 8,241,649

Title:Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
Abstract: Dermatological/cosmetic gel compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise (i) at least one retinoid, (ii) dispersed benzoyl peroxide and (iii) at least one pH-independent gelling agent, formulated into (iv) a physiologically acceptable medium therefor.
Inventor(s): Orsoni; Sandrine (Mandelieu, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma Research & Development (FR)
Application Number:13/103,613
Patent Claims: 1. A physiologically acceptable aqueous gel composition for once-daily treatment of common acne comprising: 0.1% adapalene and/or at least one pharmaceutically acceptable salt thereof; 2.5% to 5% dispersed benzoyl peroxide; and 3.5% to less than 4% acrylamide sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80 gelling agent, said percentages being based on the weight of the total aqueous gel composition.

2. A product for the once-daily treatment of acne comprising: a container; and a physiologically acceptable aqueous gel composition for once-daily treatment of common acne comprising: 0.1% adapalene and/or at least one pharmaceutically acceptable salt thereof; and 2.5% to 5% dispersed benzoyl peroxide; and 3.5% to less than 4% acrylamide sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80 gelling agent, said percentages being based on the weight of the total aqueous gel composition, wherein the container contains the aqueous gel composition.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Covington
Daiichi Sankyo
Fuji
Dow
AstraZeneca
Healthtrust
US Department of Justice
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot